Slider
Slider

Revok50 is a sterile gel syringe of intradermal injection. Revok50 is a combination of stabilised hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids consisting of Lproline, Lhydroxyproline, Lhydroxyproline, glycine and Lsylalanine.

revok50

Revok50 - Intensive Biostimulation

50mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI)  per syringe make this product a next-generation skin booster.

HA + A.As = Hydrating – Filling – Antiaging  

A unique formulation consists of stabilized hyaluronic acid with a uniform double chain length of 2,200 KD and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). 

Restores elasticity and firmness to the skin thanks to the extremely high concentration of hyaluronic acid and the synergistic action of its biologically active eutrophic ingredients.

It is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. This product combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.

revok50 revok 50
revok50 revok 50

Intensive Integral Biostimulation.

Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and  delays cell apoptosis and tissue aging. It exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.

  • Due to high molecular weight, this product is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
  • By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium.
  • This injectable HA is 2.5 times more concentrated than other products on the market. 
  • It delays cell apoptosis and tissue ageing.
  • Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.

HYALURONIC ACID + AMINO ACIDS 

It has contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.

HYALURONIC ACID AND OUR SKIN 

The skin’s native hyaluronic acid is mainly made up of chains similar to those in its composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. This process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).

revok50 revok 50
revok50 revok 50 revok50

MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS 

Injection protocol: 

  • Superficial dermis injection – medium 

  • 30G 4mm needle. 

  • Multipuncture technique. Angle < 15º: 

               * Papule (recommended separation between papules 5 – 10 mm.) 

                * Backtrace 

  • Injection volume 0.01 – 0.02 ml. per point. 

  • Treatment interval: one monthly session for three months (three sessions). 

  • Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.

revok50 revok 50 revok50

DOUBLE CROWN LIFT (DCL TECHNIQUE) 

The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez. 

The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension. 

Injection protocol: 

  • Deep dermis injection 
  • 30G needle (4 – 6 mm.) or 27/25G cannula 
  • Papula point by point technique. 
  • Injection angle >45º 
  • Injection volume 0.1 ml. per point (one 2 ml syringe per session). 
  • Treatment interval: one session per month for 3 months (three sessions). 
  • A 2 ml Revok50® syringe is used in each session

This product can treat skin dehydration 

Repair of injuries caused by environmental agents such as UV radiation and pollution. 

Connective tissue lesions such as stretch marks, scars and other dystrophies. 

Synergism with other aesthetic treatments such as fillers, lasers, microneedling. 

Fine and medium wrinkles

revok50 revok 50
revok50 revok 50
revok50 revok 50
revok50 revok 50
Revok50-stretch-marks

It sounds like the Revok50 training workshop was a successful event that brought together a diverse group of professionals in the medical and aesthetic field. The workshop aimed to provide attendees with a deeper understanding of the Revok50 product and its applications

revok50 revok 50 revok50 treatment
revok50 revok 50 revok50 treatment
revok50 revok 50 revok50 treatment
revok50 revok 50 revok50 treatment
revok50 revok 50 revok50 treatment
revok50 revok 50 revok50 treatment

Revok50 Injection -
Revok50 Safe Injectable Hyaluronic Acid

Revok50 is a sterile gel syringe of intradermal injection. Revok50 is a combination of stabilised hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids consisting of Lproline, Lhydroxyproline, Lhydroxyproline, glycine and Lsylalanine.

Revok50 Injection -
Revok50 Safe Injectable Hyaluronic Acid

Revok50 is a sterile gel syringe of intradermal injection. Revok50 is a combination of stabilised hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids consisting of Lproline, Lhydroxyproline, Lhydroxyproline, glycine and Lsylalanine.

Revok50 Injection -
Revok50 Safe Injectable Hyaluronic Acid

Revok50 is a sterile gel syringe of intradermal injection. Revok50 is a combination of stabilised hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids consisting of Lproline, Lhydroxyproline, Lhydroxyproline, glycine and Lsylalanine.

Revok50-Intensive Biostimulation

50mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI)  per syringe make this product a next-generation skin booster.

Revok50-Intensive Biostimulation

50mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI)  per syringe make this product a next-generation skin booster.

Revok50-Intensive Biostimulation

50mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI)  per syringe make this product a next-generation skin booster.

Revok50-Intensive Biostimulation

HA + A.As = Hydrating – Filling – Antiaging    A unique formulation consists of stabilized hyaluronic acid with a uniform double chain length of 2,200 KD and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl).   Restores elasticity and firmness to the skin thanks to the extremely high concentration of hyaluronic acid and the synergistic action of its biologically active eutrophic ingredients.

Revok50-Intensive Biostimulation

HA + A.As = Hydrating – Filling – Antiaging    A unique formulation consists of stabilized hyaluronic acid with a uniform double chain length of 2,200 KD and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl).   Restores elasticity and firmness to the skin thanks to the extremely high concentration of hyaluronic acid and the synergistic action of its biologically active eutrophic ingredients.

Revok50-Intensive Biostimulation

HA + A.As = Hydrating – Filling – Antiaging    A unique formulation consists of stabilized hyaluronic acid with a uniform double chain length of 2,200 KD and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl).   Restores elasticity and firmness to the skin thanks to the extremely high concentration of hyaluronic acid and the synergistic action of its biologically active eutrophic ingredients.

What is Revok50?

It is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. This product combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.

What is Revok50?

It is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. This product combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.

What is Revok50?

It is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. This product combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.

Benefit of Revok50?

Intensive Integral Biostimulation.  Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and  delays cell apoptosis and tissue aging. It exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.

Benefit of Revok50?

Intensive Integral Biostimulation.  Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and  delays cell apoptosis and tissue aging. It exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.

Benefit of Revok50?

Intensive Integral Biostimulation.  Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and  delays cell apoptosis and tissue aging. It exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.

Benefit of Revok50?

Due to high molecular weight, this product is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects. By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium. This injectable HA is 2.5 times more concentrated than other products on the market.  It delays cell apoptosis and tissue ageing. Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.

Benefit of Revok50?

Due to high molecular weight, this product is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects. By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium. This injectable HA is 2.5 times more concentrated than other products on the market.  It delays cell apoptosis and tissue ageing. Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.

Benefit of Revok50?

Due to high molecular weight, this product is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects. By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix’s electrolytic equilibrium. This injectable HA is 2.5 times more concentrated than other products on the market.  It delays cell apoptosis and tissue ageing. Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.

Composition of Revok50

HYALURONIC ACID + AMINO ACIDS   It has contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.  HYALURONIC ACID AND OUR SKIN   The skin’s native hyaluronic acid is mainly made up of chains similar to those in its composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. This process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).

Composition of Revok50

HYALURONIC ACID + AMINO ACIDS   It has contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.  HYALURONIC ACID AND OUR SKIN   The skin’s native hyaluronic acid is mainly made up of chains similar to those in its composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. This process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).

Composition of Revok50

HYALURONIC ACID + AMINO ACIDS   It has contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.  HYALURONIC ACID AND OUR SKIN   The skin’s native hyaluronic acid is mainly made up of chains similar to those in its composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. This process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).

Therapeutic Uses of Revok50

MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS  Injection protocol:  Superficial dermis injection – medium   30G 4mm needle.   Multipuncture technique. Angle < 15º:                  * Papule (recommended separation between papules 5 – 10 mm.)                   * Backtrace   Injection volume 0.01 – 0.02 ml. per point.   Treatment interval: one monthly session for three months (three sessions).   Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.

Therapeutic Uses of Revok50

MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS  Injection protocol:  Superficial dermis injection – medium   30G 4mm needle.   Multipuncture technique. Angle < 15º:                  * Papule (recommended separation between papules 5 – 10 mm.)                   * Backtrace   Injection volume 0.01 – 0.02 ml. per point.   Treatment interval: one monthly session for three months (three sessions).   Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.

Therapeutic Uses of Revok50

MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS  Injection protocol:  Superficial dermis injection – medium   30G 4mm needle.   Multipuncture technique. Angle < 15º:                  * Papule (recommended separation between papules 5 – 10 mm.)                   * Backtrace   Injection volume 0.01 – 0.02 ml. per point.   Treatment interval: one monthly session for three months (three sessions).   Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.

Therapeutic Uses of Revok50

DOUBLE CROWN LIFT (DCL TECHNIQUE)  The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.  The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.  Injection protocol:  Deep dermis injection  30G needle (4 – 6 mm.) or 27/25G cannula  Papula point by point technique.  Injection angle >45º  Injection volume 0.1 ml. per point (one 2 ml syringe per session).  Treatment interval: one session per month for 3 months (three sessions).  A 2 ml Revok50® syringe is used in each session

Therapeutic Uses of Revok50

DOUBLE CROWN LIFT (DCL TECHNIQUE)  The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.  The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.  Injection protocol:  Deep dermis injection  30G needle (4 – 6 mm.) or 27/25G cannula  Papula point by point technique.  Injection angle >45º  Injection volume 0.1 ml. per point (one 2 ml syringe per session).  Treatment interval: one session per month for 3 months (three sessions).  A 2 ml Revok50® syringe is used in each session

Therapeutic Uses of Revok50

DOUBLE CROWN LIFT (DCL TECHNIQUE)  The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez.  The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension.  Injection protocol:  Deep dermis injection  30G needle (4 – 6 mm.) or 27/25G cannula  Papula point by point technique.  Injection angle >45º  Injection volume 0.1 ml. per point (one 2 ml syringe per session).  Treatment interval: one session per month for 3 months (three sessions).  A 2 ml Revok50® syringe is used in each session

Indications of Revok50

This product can treat skin dehydration 

Repair of injuries caused by environmental agents such as UV radiation and pollution. 

Connective tissue lesions such as stretch marks, scars and other dystrophies. 

Synergism with other aesthetic treatments such as fillers, lasers, microneedling. 

Fine and medium wrinkles

Indications of Revok50

This product can treat skin dehydration 

Repair of injuries caused by environmental agents such as UV radiation and pollution. 

Connective tissue lesions such as stretch marks, scars and other dystrophies. 

Synergism with other aesthetic treatments such as fillers, lasers, microneedling. 

Fine and medium wrinkles

Indications of Revok50

This product can treat skin dehydration 

Repair of injuries caused by environmental agents such as UV radiation and pollution. 

Connective tissue lesions such as stretch marks, scars and other dystrophies. 

Synergism with other aesthetic treatments such as fillers, lasers, microneedling. 

Fine and medium wrinkles